PureWager Group, LLC and SCCG Management Form Strategic Partnership to Launch Vertically Integrated Gaming Platform

LAS VEGAS, July 28, 2025 (GLOBE NEWSWIRE) — PureWager Group, LLC, an emerging leader in next-generation sports betting technology, has entered into a strategic partnership with SCCG Management, a premier global advisory firm in the gaming industry. Backed by 22 X Ventures, this collaboration forms a vertically integrated gaming collective from day one–merging PureWager's innovative […]

Oriental Rise Holding Limited Signs Non-Binding Letter of Intent to Acquire Daohe and Minji

(NASDAQ:ORIS), NINGDE, China, July 28, 2025 (GLOBE NEWSWIRE) — Oriental Rise Holdings Limited (“Oriental Rise” or the “Company”) (NASDAQ: ORIS), an integrated tea supplier in mainland China, today announced that it has entered into a non-binding letter of intent (“LOI”) to acquire 100 percent of the equity interests of Fujian Daohe Tea Technology Co., Ltd.

Enlivex Reaffirms August 18, 2025 As Target Date For Announcement of Phase II Topline Data

(NASDAQ:ENLV), Nes-Ziona, Israel, July 28, 2025 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that all 134 patients in its Phase II stage of its randomized, controlled, blinded Phase I/II trial of Allocetra(TM) in patients with moderate to severe knee osteoarthritis, have completed a follow-up

Smith Profits Offers Shriners Children’s Hospital the Opportunity to Transform Young Patients into #1 Best Selling Authors Through Patriotic Book Series

WINTER GARDEN, Fla., July 28, 2025 (GLOBE NEWSWIRE) — Smith Profits, the Winter Garden, Florida-based business consulting and publishing company, announced a groundbreaking opportunity for Shriners Children's Hospital to launch “WHAT I LOVE ABOUT AMERICA!” – a patriotic book series that transforms young Americans into #1 Best Selling Authors. A Media Snippet accompanying this announcement

Fly-E Group, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement

(NASDAQ:FLYE), NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) — Fly-E Group, Inc. (Nasdaq: FLYE) (“Fly-E” or the “Company”), an electric vehicle company engaged in designing, installing, selling, and renting smart electric motorcycles, electric bikes, and electric scooters, today announced that it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC

Citizens Community Bancorp, Inc. Reports Second Quarter 2025 Earnings of $0.33 Per Share; Board of Directors Authorize 5% Stock Buyback Authorization

(NasdaqGM:CZWI), EAU CLAIRE, Wis., July 28, 2025 (GLOBE NEWSWIRE) — Citizens Community Bancorp, Inc. (the “Company”) (Nasdaq: CZWI), the parent company of Citizens Community Federal N.A. (the “Bank” or “CCFBank”), today reported earnings of $3.3 million and earnings per diluted share of $0.33 for the second quarter ended June 30, 2025, compared to $3.2 million

Blink Charging Teams with dfYOUNG to Offer Streamlined EV Charger and Fleet Management Services for Corporate Salesforce Customers

(NASDAQ:BLNK), New Collaboration Delivers a Turnkey Approach for Organizations with Electric Vehicle Salesforce Teams Nationwide. Bowie, Md., July 28, 2025 (GLOBE NEWSWIRE) — Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global owner, operator and provider of electric vehicle (EV) charging equipment and services, has announced a strategic collaboration with logistics solutions

Reliance Global Group Schedules Second Quarter 2025 Financial Results and Business Update Conference Call

(NASDAQ:RELI),(NASDAQ:RELIW), Lakewood, NJ, July 28, 2025 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (NASDAQ: RELI) (“Reliance” or the “Company”), announced today that it will host a conference call Wednesday, July 30, 2025, at 4:30 PM Eastern Time to discuss financial results for the second quarter 2025 and provide a business update. The conference call will

FibroBiologics Files Patent for Methods of Generating Multipotent Cells from Donor Tissue for Clinical Applications

(NASDAQ:FBLG), HOUSTON, July 28, 2025 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced the filing of a patent application with the United States Patent and

Scroll to Top